Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Differences in metabolic processes in normal and cancer cells (e.g. hypoxia – low oxygen) present opportunities for targeted therapies, but can also interfere with standard treatments such as radiotherapy. These metabolic differences are driven by local, genetic and environmental factors and other co-morbidities such as obesity. It is therefore important to understand hypoxia, signalling, nucleotide metabolism, obesity and drug associated changes to metabolism and how they affect cell behaviour.